273 related articles for article (PubMed ID: 22762277)
1. Topical delivery of steroids in inflammatory bowel disease.
Girlich C; Scholmerich J
Curr Drug Deliv; 2012 Jul; 9(4):345-9. PubMed ID: 22762277
[TBL] [Abstract][Full Text] [Related]
2. Drug therapy of inflammatory bowel disease.
Sack DM; Peppercorn MA
Pharmacotherapy; 1983; 3(3):158-76. PubMed ID: 6136027
[TBL] [Abstract][Full Text] [Related]
3. [Local or systemic treatment of inflammatory bowel diseases?].
Schmassmann A; Halter F
Ther Umsch; 1993 Feb; 50(2):94-9. PubMed ID: 8096092
[TBL] [Abstract][Full Text] [Related]
4. Second-generation corticosteroids for the treatment of Crohn's disease and ulcerative colitis: more effective and less side effects?
De Cassan C; Fiorino G; Danese S
Dig Dis; 2012; 30(4):368-75. PubMed ID: 22796798
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroids for the management of ulcerative colitis and Crohn's disease.
Jewell DP
Gastroenterol Clin North Am; 1989 Mar; 18(1):21-34. PubMed ID: 2646220
[TBL] [Abstract][Full Text] [Related]
6. Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis.
Hirayama D; Hyodo S; Morita K; Nakase H
J Gastroenterol; 2024 May; 59(5):389-401. PubMed ID: 38492011
[TBL] [Abstract][Full Text] [Related]
7. Current status of drug therapy for inflammatory bowel disease.
Peppercorn MA
Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era-Results from the Dutch Population-Based IBDSL Cohort.
Jeuring SFG; Biemans VBC; van den Heuvel TRA; Zeegers MP; Hameeteman WH; Romberg-Camps MJL; Oostenbrug LE; Masclee AAM; Jonkers DMAE; Pierik MJ
Am J Gastroenterol; 2018 Mar; 113(3):384-395. PubMed ID: 29317770
[TBL] [Abstract][Full Text] [Related]
9. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
Hanauer SB; Stathopoulos G
Drug Saf; 1991; 6(3):192-219. PubMed ID: 1676590
[TBL] [Abstract][Full Text] [Related]
10. Oral locally active steroids in inflammatory bowel disease.
Nunes T; Barreiro-de Acosta M; Marin-Jiménez I; Nos P; Sans M
J Crohns Colitis; 2013 Apr; 7(3):183-91. PubMed ID: 22784947
[TBL] [Abstract][Full Text] [Related]
11. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
12. Observational Study of Perspectives of Inflammatory Bowel Disease Patients Concerning the Use of Corticosteroids.
Asl Baakhtari S; McCombie A; Ten Bokkel Huinink S; Irving P; Siegel CA; Mulder R; Mulder CJ; Gearry R
Dig Dis; 2018; 36(1):33-39. PubMed ID: 28866661
[TBL] [Abstract][Full Text] [Related]
13. New steroids and new salicylates in inflammatory bowel disease: a critical appraisal.
Campieri M
Gut; 2002 May; 50 Suppl 3(Suppl 3):III43-6. PubMed ID: 11953332
[TBL] [Abstract][Full Text] [Related]
14. Current medical therapy for inflammatory bowel disease.
Bonner GF
South Med J; 1996 Jun; 89(6):556-66. PubMed ID: 8638193
[TBL] [Abstract][Full Text] [Related]
15. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
[TBL] [Abstract][Full Text] [Related]
16. Review article: systemic and topical steroids in inflammatory bowel disease.
Schölmerich J
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():66-74. PubMed ID: 15352897
[TBL] [Abstract][Full Text] [Related]
17. Nonenzymatic Serum Antioxidant Capacity in IBD and Its Association with the Severity of Bowel Inflammation and Corticosteroids Treatment.
Neubauer K; Kempinski R; Matusiewicz M; Bednarz-Misa I; Krzystek-Korpacka M
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30986917
[No Abstract] [Full Text] [Related]
18. Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease.
Klotz U; Schwab M
Adv Drug Deliv Rev; 2005 Jan; 57(2):267-79. PubMed ID: 15555742
[TBL] [Abstract][Full Text] [Related]
19. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
20. The use of oral corticosteroids in inflammatory bowel diseases in Italy: An IG-IBD survey.
Fascì-Spurio F; Meucci G; Papi C; Saibeni S;
Dig Liver Dis; 2017 Oct; 49(10):1092-1097. PubMed ID: 28801181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
